Preparation method of plant volatile oil liposome precursor as well as auxiliary material composition and application thereof

By using sorbitol, β-cyclodextrin, konjac powder and microcrystalline cellulose auxiliary material compositions, the stability of plant volatile oil liposomes in spray drying and storage is solved, and its bioavailability is improved and The encapsulation rate meets the demand for tableting production and achieves stable liposome precursor preparation.

CN119055782APending Publication Date: 2024-12-03GUANGZHOU LIKEFOOD BIOTECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410511824.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-04-26
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

There are stability problems in plant volatile oil liposomes in spray drying and storage, resulting in low encapsulation rate, large average particle size and oxidation of phospholipid components, affecting their long-term preservation and bioavailability.

Method used

Using auxiliary material compositions of sorbitol, β-cyclodextrin, konjac powder and microcrystalline cellulose, plant volatile oil liposome precursors are prepared through low-temperature drying and spray drying techniques to provide thermal stability and lyophilization protection to ensure Stability and encapsulation rate of liposomes.

Benefits of technology

The storage stability and bioavailability of plant volatile oil liposome precursors are improved, high retention rate and adaptability to tableting production are ensured, subsequent processing processes are simplified, and sustained release and thermal stability protection are achieved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004812146860000081
    Figure BDA0004812146860000081
  • Figure BDA0004812146860000091
    Figure BDA0004812146860000091
  • Figure BDA0004812146860000092
    Figure BDA0004812146860000092
Patent Text Reader

Abstract

The invention provides a preparation method of a plant volatile oil liposome precursor, an auxiliary material composition used by the plant volatile oil liposome precursor and application of the plant volatile oil liposome precursor. The auxiliary material composition comprises sorbitol, beta-cyclodextrin, konjac powder and microcrystalline cellulose; the application method comprises the following steps: fully stirring a plant volatile oil liposome liquid dispersion system with sorbitol and beta-cyclodextrin, carrying out freeze drying to obtain a powdery compound, adding the compound into a konjac powder aqueous solution, fully stirring, adding microcrystalline cellulose, and carrying out spray drying on the obtained mixed solution to obtain the plant volatile oil liposome precursor. According to the auxiliary material composition provided by the invention, the storage stability of a plant volatile oil liposome precursor can be improved, and after an accelerated stability experiment, the retention rate of plant volatile oil is still relatively high; and under the condition of not additionally supplementing a filling agent and a lubricating agent, the auxiliary material composition participates in the preparation of a liposome precursor, and can be directly suitable for the production of tablets.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of liposomes, and in particular relates to a preparation method of a plant volatile oil liposome precursor and an auxiliary material composition and application thereof. Background Art

[0002] As a drug delivery system, liposome technology has advantages in drug protection, improving drug bioavailability and achieving targeted drug delivery. Plant volatile oils, such as agarwood, cinnamon, mint and other plant volatile oil extracts with medicinal value, have rich biological activities and multiple therapeutic effects. However, in practical applications, due to the poor water solubility and volatility of such ingredients, plant volatile oils face problems such as low bioavailability. Applying liposome technology to the study of plant volatile oils can improve their bioavailability and nutritional health effects. The preparation method of liposomes has an important influence on the stability, solubility, targeting and other properties of liposomes. In order to avoid the use of highly toxic organic solvents such as chloroform and ether in the preparation process of liposomes, the preparation method using ethanol as the organic phase, such as the ethanol injection method, after further replacing reagents that may be harmful to the human body, the liposomes produced have the problems of low encapsulation rate and large average particle size. The stability of the prepared liposomes is also low. Long-term storage is easy to aggregate and the particle size becomes larger. The phospholipid components are also easily oxidized, resulting in a decrease in encapsulation rate. Spray drying is a commonly used and relatively economical method to increase the stability of liposomes through microencapsulation, converting liposomes from liquid media to solid form, expanding their storage and applicability. At this time, the form of liposomes is called liposome precursors. However, the high temperature and airflow treatment involved in spray drying can easily destroy the originally less stable liposomes, affecting the long-term storage of liposomes and the quality of renaturation after water dissolution. The subsequent dosage form processing of liposome precursors - microcapsule powders, such as tableting, etc., is also prone to cause rupture of liposomes and leakage of volatile oils due to the high pressure, resulting in poor long-term storage stability.

[0003] In order to overcome the above problems, it is particularly important to find an auxiliary material formula and a preparation method thereof that can provide stability protection for plant volatile oil liposomes during spray drying and subsequent storage.

[0004] Patent application publication number CN114711288A discloses a cinnamaldehyde solid liposome nanoparticle with high stability, with glyceryl monostearate as the main component of the wall material, and poloxamer-188 to improve the stability of the plasmid nanoparticles. The cinnamaldehyde solid lipid nanoparticles are solid at room temperature after freeze-drying, the fluidity of the particle wall is reduced by glyceryl monostearate, the stability is better, it is easy to store and transport, and it is convenient to add water and disperse again. However, although poloxamer-188, which is indispensable to this scheme, is a safe pharmaceutical excipient, it may not be suitable for the food field, and the comparative test of this scheme shows that its core material encapsulation rate and stability other than cinnamaldehyde are poor, and it has certain pertinence to cinnamaldehyde. Patent application publication number CN116473231A discloses a blueberry lutein ester nanoliposome and its preparation method and application, the liposome uses medium-chain glyceryl fatty acid esters, mono- and di-stearate glyceryl, and soybean lecithin to embed the active ingredients, and prepares nano-scale particles by high-pressure homogenization. Accelerated stability tests show that by adding β-cyclodextrin and gum arabic to the liposome liquid dispersion and spray drying to prepare solid particles, the liposomes can have excellent high temperature stability. However, for the plant volatile oil liposomes produced by replacing reagents that may be harmful to the human body, the solution for improving thermal stability in the application, i.e., directly adding β-cyclodextrin and gum arabic for spray drying, may not be universal for different liposomes, and the formula does not mention the tableting performance of the liposome solid particles.

[0005] The long-term storage of plant essential oil liposomes faces the dual effects of plant essential oil deterioration and decreased physical and chemical stability of liposomes, resulting in a rapid decrease in liposome encapsulation efficiency. In view of the storage stability problem of liposomes, the prior art mainly adds special ingredients in the liposome preparation process to improve stability, solving this problem from the liposome preparation level. Different from this, the present invention proposes a new auxiliary material composition and its application in improving the storage stability of plant essential oil liposome precursors. The plant essential oil liposomes prepared by the traditional method of replacing toxic organic reagents have a large average particle size and low stability. However, when such liposomes are spray-dried to prepare liposome precursors, the auxiliary material composition of the present invention is used to enable the liposome precursors to obtain excellent storage stability. After long-term storage and rehydration and reconstruction, the retention rate of liposomes to plant essential oils is still high. Summary of the invention

[0006] In order to improve the storage stability of plant essential oil liposome precursors in the prior art and enable the liposome precursors to be more conveniently prepared into tablets that are convenient for storage and transportation, an object of the present invention is to provide a group of auxiliary material compositions for improving the storage stability of plant essential oil liposome precursors.

[0007] Another object of the present invention is to provide a method for preparing a plant essential oil liposome precursor with good storage stability. The third object of the present invention is to provide the application of the prepared plant essential oil liposome precursor.

[0008] To achieve the above object, the present invention adopts the following technical solutions:

[0009] An auxiliary material composition for improving the storage stability of a plant volatile oil liposome precursor, the auxiliary material composition comprising sorbitol, β-cyclodextrin, konjac flour and microcrystalline cellulose. Further, when the plant volatile oil liquid dispersion is used to prepare the plant volatile oil liposome precursor, the volume mass ratio of sorbitol to the liposome liquid dispersion is mL:g=48-52:2-4, the mass ratio of β-cyclodextrin to sorbitol is 2-4:1-3; the mass ratio of liposome freeze-dried powder to konjac flour and microcrystalline cellulose is 20-30:1.6-2.4:2-4.

[0010] Use of the composition as described above in preparing plant volatile oil liposome precursors.

[0011] The use of the composition as described above in improving the storage stability of plant essential oil liposome precursors.

[0012] A method for preparing a plant volatile oil liposome precursor comprises the following steps:

[0013] S1, preparing plant volatile oil into a liposome liquid dispersion system;

[0014] S2, mixing the liposome liquid dispersion system and sorbitol, adding β-cyclodextrin to form a uniform and thin porridge-like dispersion system, and then drying at low temperature to obtain liposome freeze-dried powder;

[0015] S3, adding the liposome freeze-dried powder to the konjac flour solution, stirring evenly, then adding microcrystalline cellulose, and spray-drying the mixed suspension to obtain a volatile oil liposome precursor.

[0016] In the preparation method as described above, preferably, in step S2, the volume mass ratio of the liposome liquid dispersion system to sorbitol is mL:g=48-52:2-4; the mass ratio of sorbitol to β-cyclodextrin is 2-4:1-3.

[0017] In the preparation method as described above, preferably, in step S2, the low-temperature drying condition is -25°C, and the low-temperature drying is for 24 hours.

[0018] In the preparation method as described above, preferably, in step S3, the konjac flour solution is a solution of konjac flour and water mixed in a mass volume ratio of g:mL=1:100.

[0019] In the preparation method as described above, preferably, in step S3, the mass ratio of konjac flour to liposome freeze-dried powder and microcrystalline cellulose is 1.6-2.4:20-30:2-4.

[0020] In the preparation method as described above, preferably, in step S3, the spray drying conditions are as follows: an inlet temperature of 110° C., a feed rate of 8 mL / min, an air flow rate of 300 L / h, and a nozzle diameter of 0.7 mm.

[0021] In the preparation method as described above, preferably, the obtained volatile oil liposome precursor is used in the preparation of tablets.

[0022] The beneficial effects of the present invention are:

[0023] (1) Compared with the excipients used in the existing process of preparing liposome precursors, the excipient composition provided by the present invention has a good protective effect on plant volatile oil liposomes. After the accelerated stabilization experiment, the retention rate of plant volatile oil is still relatively high;

[0024] (2) Without the need to add additional fillers or lubricants, the use scheme of the auxiliary material composition of the present invention can enable the produced liposome precursor to be directly used in the production of tablets, which can be directly compressed into tablets, with a friability of less than 1% and a long continuous compression time. Although the prior art scheme can also be processed and produced in the form of tablets after adding an appropriate amount of fillers and lubricants commonly used in tablet preparation such as sugar alcohols, the liposome precursor obtained by the present invention can be directly adapted to tableting production, simplifying the subsequent processing and production process, which has practical significance for improving production efficiency.

[0025] (3) The combination of selected excipients not only provides stability protection for liposomes, but also realizes an organic combination of sustained-release wall material, microcapsule wall material, lyophilization protective agent, thermal stability protective agent, filler, and lubricant, which has outstanding and unexpected effects.

[0026] The present invention provides a method for preparing a liposome precursor of plant essential oil. After the obtained liposome precursor is subjected to an accelerated stability test and then rehydrated and reconstructed, the liposome precursor still has a high retention rate for the plant essential oil, indicating that the liposome precursor prepared by the auxiliary material composition proposed by the present invention has good storage stability. DETAILED DESCRIPTION

[0027] The invention provides an auxiliary material composition comprising beta-cyclodextrin, microcrystalline cellulose, konjac flour, sorbitol, and provides the application of the composition in improving the storage stability of plant volatile oil liposome precursors, specifically first fully stirring the plant volatile oil liposome liquid dispersion system with sorbitol and beta-cyclodextrin, freeze drying to obtain a powdery composite, then the composite is added to the konjac flour aqueous solution, microcrystalline cellulose is added after fully stirring, and the obtained mixed solution is spray-dried to obtain the plant volatile oil liposome precursor (microcapsule powder). The auxiliary material composition can effectively improve the storage stability of the plant volatile oil liposome precursor, improve the plant volatile oil bioavailability. Beta-cyclodextrin, microcrystalline cellulose, konjac flour and sorbitol are adopted in the present invention to provide heat stability protection and freeze-drying protection for the preparation process of liposome respectively, and unexpectedly, the selection and coordination of the above protective auxiliary materials make the products obtained therefrom directly adapt to the tableting process.

[0028] The following examples are used to further illustrate the present invention, but should not be construed as limiting the present invention. Without departing from the spirit and substance of the present invention, modifications or substitutions made to the present invention all belong to the scope of the present invention.

[0029] Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art. Unless otherwise specified, all reagents used in the present method are of analytical grade or above.

[0030] Preparation of agarwood volatile oil liposomes: accurately weigh 320 mg soybean lecithin, 80 mg soybean sterols and 100 mg agarwood essential oil, mix the above substances and dissolve them in 10 mL anhydrous ethanol, stir slowly to form a uniform organic liquid dispersion. Inject the organic liquid dispersion into 100 mL 0.01 mol·mL preheated at 60°C. -1 The mixture was stirred rapidly at 1000 rpm in a phosphate buffer solution with a magnetic stirrer. After the organic liquid dispersion was injected, the stirring speed was reduced to 500 rpm. The mixture was stirred slowly for about 6 hours until the ethanol was completely evaporated. Then, the mixture was ultrasonically treated at 96W and 40KHz for 10 minutes to obtain the agarwood volatile oil liposome liquid dispersion. -1 The phosphate buffer solution is specifically composed of a concentration of 0.1 mol·L -1 Na2HPO4 and 0.1mol·L -1 and NaH2PO4 in a volume ratio of 3.42:1, and the pH value is 7.4. The above operation is repeated to prepare liposomes to meet the usage requirements of subsequent steps.

[0031] Preparation of liposomes without agarwood volatile oil: The preparation method is the same as that of liposomes with agarwood volatile oil, except that agarwood essential oil is not added during the preparation process, and the addition amounts and operations of the remaining components are the same.

[0032] Example 1

[0033] Take 100mL of agarwood volatile oil liposome liquid dispersion and gradually add 6g of sorbitol in small batches under 500rpm low-speed magnetic stirring. After complete dissolution, continue to gradually add 4g of β-cyclodextrin in small batches. After a uniform and thin porridge-like dispersion is formed, stop stirring, let it stand for 5min, and disperse the liquid dispersion on multiple surface dishes. Dry at -25℃ for 24h to obtain liposome freeze-dried powder. Repeat the above operation to prepare liposome freeze-dried powder to meet the needs of subsequent processes.

[0034] Dissolve 2 g of konjac flour in 200 mL of pure water, add 20 g of liposome freeze-dried powder, stir thoroughly, add 3.75 g of microcrystalline cellulose after the liposome freeze-dried powder forms a uniform dispersion system in the konjac flour solution again, stir magnetically at a low speed of 500 rpm for 5 minutes, spray dry the obtained mixed suspension, control the inlet temperature at 110°C, the feed rate at 8 mL / min, the air flow rate at 300 L / h, and the nozzle diameter at 0.7 mm to obtain agarwood volatile oil liposome microcapsule powder.

[0035] Example 2

[0036] Preparation of cinnamon volatile oil liposomes: 320 mg soybean lecithin, 80 mg soybean sterols and 100 mg cinnamon essential oil were accurately weighed, mixed and dissolved in 10 mL anhydrous ethanol, and stirred slowly to form a uniform organic liquid dispersion. The organic liquid dispersion was injected into 100 mL 0.01 mol·mL preheated at 60°C. -1 The mixture was stirred in a phosphate buffer solution with a magnetic stirrer at 1000 rpm, and the stirring speed was reduced to 500 rpm after the organic liquid dispersion was injected, and the mixture was slowly stirred for about 6 hours until the ethanol was completely evaporated, and then ultrasonicated at 96W and 40KHz for 10 minutes to obtain a cinnamon volatile oil liposome liquid dispersion. The cinnamon volatile oil liposome adopts the auxiliary material composition of the present invention, i.e., sorbitol, β-cyclodextrin, konjac flour and microcrystalline cellulose, to prepare a liposome precursor by spray drying, and the operating steps are the same as those in Example 1, except that the above-prepared cinnamon volatile oil liposome liquid dispersion is adopted.

[0037] Example 3

[0038] Preparation of tangerine peel volatile oil liposome: accurately weigh 320mg soybean lecithin, 80mg soybean sterol and 100mg tangerine peel essential oil, dissolve in 10mL absolute ethanol after above material mixing, slowly stir, form uniform organic liquid dispersion.Inject organic liquid dispersion into 100mL 0.01molmL-1 phosphate buffer of 60 ℃ of constant temperature preheating, magnetic stirring apparatus 1000rpm stirs quickly, and reducing stirring speed after organic liquid dispersion is injected is 500rpm, slowly stirs about 6h to ethanol complete evaporation, 96W, 40KHz ultrasonic process 10min subsequently, obtains tangerine peel volatile oil liposome liquid dispersion.Tangerine peel volatile oil liposome adopts auxiliary material composition of the present invention and is sorbitol, beta-cyclodextrin, konjac powder and microcrystalline cellulose carry out spray drying to prepare tangerine peel volatile oil liposome precursor, and operating steps is with embodiment 1, and different is the tangerine peel volatile oil liposome liquid dispersion adopting above-mentioned preparation.

[0039] Comparative Example 1: Take 100 mL of the ultrasonically treated agarwood volatile oil liposome liquid dispersion, gradually add 4 g of β-cyclodextrin in small batches under a low-speed magnetic stirring of 500 rpm. After a uniform and thin porridge-like dispersion is formed, stop stirring and let stand for 5 minutes. The obtained mixed suspension is spray dried, and the inlet temperature is controlled at 110°C, the feed rate is 8 mL / min, the air flow rate is 300 L / h, and the nozzle diameter is 0.7 mm to obtain agarwood volatile oil liposome precursor microcapsule powder.

[0040] Comparative Example 2: Take 100 mL of the ultrasonically treated agarwood volatile oil liposome liquid dispersion, add 6 g of sorbitol in small batches gradually under 500 rpm low-speed magnetic stirring, and continue to add 4 g of β-cyclodextrin in small batches after complete dissolution. After a uniform and thin porridge-like dispersion is formed, stop stirring, let it stand for 5 minutes, and dry it at -25°C for 24 hours to obtain liposome precursor freeze-dried powder.

[0041] Comparative Example 3: Take 100 mL of the ultrasonically treated agarwood volatile oil liposome liquid dispersion, gradually add 4 g of β-cyclodextrin and 3.5 g of gum arabic in small batches under a low-speed magnetic stirring of 500 rpm. After a uniform and thin porridge-like dispersion is formed, stop stirring and let stand for 5 minutes. The obtained mixed suspension is spray dried, and the inlet temperature is controlled at 110°C, the feed rate is 8 mL / min, the air flow rate is 300 L / h, and the nozzle diameter is 0.7 mm to obtain agarwood volatile oil liposome precursor microcapsule powder.

[0042] Comparative Example 4: Take 100 mL of the ultrasonically treated agarwood volatile oil liposome liquid dispersion, gradually add 4 g of β-cyclodextrin and 3.5 g of chitosan in small batches under a low-speed magnetic stirring of 500 rpm. After a uniform and thin porridge-like dispersion is formed, stop stirring and let stand for 5 minutes. The obtained mixed suspension is spray dried, and the inlet temperature is controlled at 110°C, the feed rate is 8 mL / min, the air flow rate is 300 L / h, and the nozzle diameter is 0.7 mm to obtain agarwood volatile oil liposome precursor microcapsule powder.

[0043] Comparative Example 5: Same as Example 1, except that the amount of β-cyclodextrin was adjusted to 2 g.

[0044] Comparative Example 6: Same as Example 1, except that the amount of konjac flour was adjusted to 1.2 g, and the amount of microcrystalline cellulose was adjusted to 4.55 g accordingly.

[0045] Comparative Example 7: Same as Example 1, except that the amount of konjac flour was adjusted to 4 g, and the amount of microcrystalline cellulose was adjusted to 1.4 g accordingly.

[0046] Experiment 1

[0047] Agarwood tetraol, which has a high content in agarwood volatile oil, was used as an indicator to measure the change in the content of agarwood volatile oil, and a simple content determination of agarwood volatile oil was performed using ultraviolet spectrophotometry. The wall-breaking-low-speed centrifugation method was combined with ultraviolet spectrophotometry to calculate the encapsulation rate of agarwood volatile oil liposomes, and the liposomes obtained by various preparation methods in the above embodiments and comparative examples were compared after being stored at 4°C, 20°C, and 50°C without light for one month. The encapsulation rate of the liposome precursor reconstructed after rehydration was changed.

[0048] Encapsulation efficiency detection: 100 mg of agarwood volatile oil liposome precursor was redissolved in 10 mL of phosphate buffer, 10 mL of petroleum ether was added, mixed evenly, centrifuged at 4000 rpm for 15 min, the upper petroleum ether layer was taken into a 25 mL volumetric flask, and the extraction was repeated twice. The petroleum ether layers were combined and the volume was adjusted to the scale with petroleum ether. Petroleum ether was used as a blank, and 1.5 mL of it was taken to measure the sample absorbance at 252 nm in an ultraviolet spectrophotometer, which was calculated as A1; 100 mg of agarwood volatile oil liposome precursor was redissolved in 10 mL of phosphate buffer, 10 mL of petroleum ether was added, mixed evenly, and 1 mL of 10% Triton was added. X-100 methanol solution was used as a demulsifier, and ultrasonic demulsification was performed at 96W power for 10 minutes. The product was centrifuged at 4000rpm for 15 minutes. The upper petroleum ether layer was taken into a 25mL volumetric flask. After repeated extraction twice, the petroleum ether layers were combined and the volume was fixed to the mark with petroleum ether. The absorbance of the liposome solution after the above extraction was determined by the same method and was recorded as A2. 100 mg of the liposome precursor prepared without adding agarwood volatile oil was redissolved in 10mL of phosphate buffer, and the absorbance of the sample was determined by the same method and recorded as A0.

[0049] ΔA1=A1-A0,ΔA2=A2-A0

[0050] Substitute ΔA1 and ΔA2 into the standard curve equation of agarwood tetraol, convert the concentration of agarwood volatile oil in the test solution, and calculate the free agarwood volatile oil content (C1) and the total agarwood volatile oil content (C2) respectively. Calculate the encapsulation rate (Y) by the following formula.

[0051] Y=1-C1 / C2×100%

[0052] Retention rate detection: The detection method is the same as the encapsulation rate detection. Take 100 mg of agarwood volatile oil liposome precursor to calculate the content of the embedded agarwood volatile oil. The content of the embedded agarwood volatile oil (C3) = the total agarwood volatile oil content (C2) - the free agarwood volatile oil content (C1)

[0053] Retention rate = volatile oil content of agarwood embedded before the test / volatile oil content of agarwood embedded after the test × 100%, the results are shown in Table 1.

[0054] Table 1 Retention rate detection of agarwood volatile oil (x±s, %, n=3)

[0055]

[0056]

[0057] The agarwood volatile oil liposome precursor prepared in Example 1 has a higher retention rate of agarwood volatile oil in the accelerated stability test. Compared with the existing schemes such as Comparative Example 2, Comparative Example 3 and Comparative Example 4, the auxiliary material composition used in the present application can enable the agarwood volatile oil liposome precursor to have a higher retention rate in the accelerated stability test at 4°C and 20°C.

[0058] The average particle size of the liposomes in the liquid dispersion was detected by dynamic light scattering, and the average particle size of the agarwood volatile oil liposomes prepared by the above method was measured to be 173nm, and the average encapsulation efficiency was 62%. Since the liposome preparation method is the same, the difference is the formula and preparation process of the auxiliary material composition, there is no significant difference in the encapsulation efficiency of the liposome precursors prepared in each embodiment and the comparative example after rehydration and reconstruction.

[0059] Experiment 2

[0060] Tablet preparation method: The liposome precursors obtained in each example and comparative example were tableted using a KORSCH XL-100 rotary tablet press. During the test, the feeder speed was fixed at 20 rpm, the tablet diameter was 9.0 mm, the target tablet weight was 0.300 g, and the preload force was set to 2 kN.

[0061] The friability of the tablets was tested with reference to the friability test method of the Chinese Pharmacopoeia 2020. Take several tablets of the liposome precursor direct compression tablets of each embodiment and comparative example, so that the total weight is about 6.5g. Use a hair dryer to blow away the powder that falls off the tablets, weigh them accurately, put them in a transparent wear-resistant plastic cylinder, and rotate them 100 times. Take them out, remove the powder in the same way, and weigh them accurately.

[0062] Qualification standards: 1. Weight loss shall not exceed 1%; 2. No broken, cracked or crushed pieces shall be detected.

[0063] Table 2 Test results of friability

[0064]

[0065]

[0066] The results of Examples 1, 2, and 3 show that the dosage form characteristics of the liposome precursor prepared by the auxiliary materials of the present invention are suitable for preparing tablets on a rotary tablet press, and there is no obvious sticking phenomenon during the tableting process, and the friability of the obtained tablets is less than 1%. Using the method of Comparative Example 1, the obtained volatile oil liposome precursor is directly tableted, and the tablet friability is greater than 1%, and the friability detection process shows a breakage situation. The volatile oil liposome precursor obtained by this method does not meet the relevant production standards for direct tableting. Using the method of Comparative Example 2, the volatile oil liposome precursor obtained by freeze-drying is directly tableted, and the tablet friability is greater than 1%. Using the method of Comparative Example 4, the obtained volatile oil liposome precursor is directly tableted, and the tablet friability is greater than 1%, and the friability detection shows cracks on the outer surface of the tablet. The volatile oil liposome precursor obtained by this method does not meet the relevant production standards for direct tableting. Using the method of Comparative Example 6, the obtained volatile oil liposome precursor is directly tableted, and the tablet friability is greater than 1%. However, the volatile oil liposome precursor obtained by this method does not meet the relevant production standards for direct tableting. Using the method of Comparative Example 7, the powder yield of the obtained volatile oil liposome precursor is low, and the friability of the tablets obtained by direct tableting meets the production standard, but there is an obvious sticking phenomenon during the tableting process, and the average continuous tableting time is 35 minutes. Using the methods of Comparative Examples 3 and 5, the obtained volatile oil liposome precursor is directly tableted, and the friability of the tablets is not significantly different from that of Example 1, and the weight loss is less than 1%, but combined with the performance of the accelerated stability test, the retention rate of agarwood volatile oil in Comparative Examples 3 and 5 is significantly worse than that in Example 1.

[0067] In conventional tableting, in order to ensure that the production quality of the obtained tablets complies with the relevant regulations, especially the requirements for friability, conventional liposome precursor production requires the appropriate addition of fillers or lubricants before tableting to adapt to tablet production. The volatile oil liposome precursor prepared by the present invention realizes an organic combination of sustained-release wall material, inclusion wall material, lyophilization protective agent, thermal stability protective agent, filler, and lubricant through the combination of selected excipients, which directly meets the needs of tablet production while providing stability protection for liposomes.

[0068] Experiment 3

[0069] To test whether the tablet production method will affect the encapsulation rate of volatile oil liposome precursors. The present invention continues to detect the retention rate of the liposome precursor powders obtained in Example 1, Comparative Example 2, Comparative Example 3 and Comparative Example 4 before and after tableting. The liposome precursor powders used in each group of this experiment are freshly prepared and have not been stored. The liposome precursor powders are prepared into tablets using the same method as Experiment 2. Tablets with a total weight of 0.5 g and 0.5 g of liposome precursor powders from the same batch before tableting were rehydrated in 50 mL of pure water at room temperature to calculate the retention rate of agarwood volatile oil. The results are shown in Table 3.

[0070] Table 3 Retention rate detection of agarwood volatile oil (x±s, %, n=3)

[0071] Group Retention rate (%) Example 1 <![CDATA[95.26±1.27 a ]]> Comparative Example 2 <![CDATA[83.14±1.55 c ]]> Comparative Example 3 <![CDATA[86.29±1.74 bc ]]> Comparative Example 4 <![CDATA[90.86±1.22 ab ]]>

[0072] The same letters in the same column indicate no significant difference (P<0.05), and different letters indicate significant difference (P>0.05)

[0073] From the retention rate results, it can be seen that the encapsulation rate of the liposome precursors prepared in each embodiment and comparative example after tableting treatment and rehydration and reconstruction is reduced compared with the precursor powder without tableting treatment, and the average retention rate of the agarwood volatile oil in Example 1 is 95.26%, which is higher than that of each comparative example. Although the retention rate of the embodiment 1 scheme after tableting treatment is not significantly higher than that of comparative example 4, combined with the results of Experiment 2, the comparative example 4 scheme is directly pressed into tablets, the tablet friability is greater than 1%, and the outer surface of the tablet is cracked, which does not meet the production standards.

[0074] Experiment 4

[0075] In order to verify the effect of the agarwood volatile oil liposome precursor prepared by the auxiliary material composition of the present invention on the bioavailability of agarwood volatile oil, this experiment investigated the bioavailability of the agarwood volatile oil liposome precursor by constructing an H22 liver cancer-bearing mouse model.

[0076] Establishment of H22 liver cancer-bearing mouse model:

[0077] The modeling subjects were SPF male Kunming mice obtained from the Guangdong Medical Experimental Animal Center. The H22 mouse liver cancer cell line was revived and cultured aseptically. After culturing to an appropriate density, the cells were collected by centrifugation at 1200 rpm for 3 min and resuspended in PBS buffer to a cell concentration of 1×10 7 The cells were centrifuged at 1200 rpm for 3 min and diluted with saline to a cell concentration of 1×10 7 The H22 liver cancer-bearing mouse model was established by inoculating 0.2 mL / mouse subcutaneously in the axilla of the right forelimb of the mouse. The blank group was injected with normal saline only.

[0078] Experimental mouse grouping and treatment:

[0079] 40 Kunming mice were randomly divided into blank control group, model group, positive control group, agarwood volatile oil liposome group and agarwood volatile oil group, with 8 mice in each group. Except for the blank group, each group of mice was inoculated with H22 cell tumor strain.

[0080] The agarwood volatile oil liposome precursor prepared in Example 1 was rehydrated in pure water containing 1% Tween 80 to reconstruct liposomes; the agarwood volatile oil was diluted in pure water containing 1% Tween 80 to form a liquid dispersion system. The agarwood volatile oil liposome group and the agarwood volatile oil group were given a daily dose of agarwood volatile oil, 20 mg / 10 g of mouse body weight, and 0.5 mL was taken for gavage each time. The mice were gavaged for 14 days starting from 24 hours after inoculation of the H22 cell tumor strain; the blank control group and the model group were gavaged with an equal volume of normal saline. The positive control group was intraperitoneally injected with 5-fluorouracil (5-FU) at a dose of 20.0 mg / kg. 24 hours after the last administration, the mice were weighed and killed by cervical dislocation, and the corresponding tissues were taken for the next experiment.

[0081] Calculation of tumor inhibition rate:

[0082] After the last oral administration, mice were weighed, blood was collected after anesthesia, and then sacrificed. Tumor tissues of mice were completely extracted and weighed to calculate the tumor inhibition rate.

[0083] Tumor inhibition rate = [1-(average tumor weight of drug administration group / average tumor weight of model group)] × 100%

[0084] Detection of tumor-related factors:

[0085] Determination of B cell lymphoma factor (BCL-2) and BCL-2 associated protein (BAX)

[0086] After the tumor tissue was rinsed with PBS buffer, the tissue was cut into pieces, 0.1 g was weighed, and after being fully mixed with 9 mL of PBS, the tissue was homogenized on ice. The homogenate was centrifuged at 5000 rpm for 10 min, and the BCL-2 and BAX contents in the tumor tissue were detected according to the instructions of the ELISA kit (Jianglai Biotechnology). The results are shown in Tables 4 and 5.

[0087] Table 4 Tumor inhibition effect of agarwood volatile oil on H22 liver cancer mice

[0088]

[0089]

[0090] The same letters in the same column indicate no significant difference (P<0.05), and different letters indicate significant difference (P>0.05)

[0091] Table 5 Effects of agarwood volatile oil on the expression of BCL-2 and BAX in H22 liver cancer mice

[0092]

[0093] The same letters in the same column indicate no significant difference (P<0.05), and different letters indicate significant difference (P>0.05)

[0094] B cell lymphoma factor (BCL-2) can promote long-term cell survival and inhibit cell apoptosis; BCL-2 associated protein (BAX) is a pro-apoptotic protein mainly located on the outer membrane of mitochondria, and the ratio of the two can reflect the survival and apoptosis status of tumor cells to a certain extent. The effects of agarwood volatile oil on the tumor inhibition rate of H22 liver cancer mice and the expression of BCL-2 and BAX in liver cancer tissues were comprehensively considered. Compared with the group taking agarwood volatile oil, the tumor inhibition rate of H22 liver cancer mice taking the agarwood volatile oil liposome precursor prepared by the present invention was improved, and the BAX / BCL-2 ratio was improved. It shows that the agarwood volatile oil liposome precursor prepared by the present invention does not affect or reduce its high bioavailability as a liposome after rehydration and reconstruction, and has better bioavailability.

Claims

1. An auxiliary material composition for improving the storage stability of plant volatile oil liposome precursors, characterized in that: The auxiliary material composition comprises sorbitol, beta-cyclodextrin, konjac powder and microcrystalline cellulose.

2. The auxiliary material composition according to claim 1, characterized in that When the plant volatile oil liquid dispersion system is used to prepare the plant volatile oil liposome precursor, the volume mass ratio of sorbitol to the liposome liquid dispersion system is mL:g=48-52:2-4, the mass ratio of beta-cyclodextrin to sorbitol is 2-4:1-3; the mass ratio of liposome freeze-dried powder to konjac powder and microcrystalline cellulose is 20-30:1.6-2.4:2-4.

3. Use of the composition according to claim 1 or 2 in preparing plant volatile oil liposome precursors.

4. Use of the composition according to claim 1 or 2 for improving the storage stability of plant essential oil liposome precursors.

5. A method for preparing a plant volatile oil liposome precursor, characterized in that: It includes the following steps: S1, preparing a liposome liquid dispersion system with plant volatile oil; S2, mixing the liposome liquid dispersion system and sorbitol, adding β-cyclodextrin to form a uniform and thin porridge-like dispersion system, and then drying at low temperature to obtain liposome freeze-dried powder; S3, adding liposome freeze-dried powder to the konjac flour solution and stirring evenly, then adding microcrystalline cellulose, and spray-drying the mixed suspension to obtain volatile oil liposome precursor.

6. The preparation method according to claim 5, characterized in that: In step S2, the volume mass ratio of the liposome liquid dispersion system and sorbitol is mL:g=48-52:2-4; the mass ratio of sorbitol to β-cyclodextrin is 2-4:1-3.

7. The preparation method according to claim 5, characterized in that: In step S2, the low-temperature drying condition is -25°C, and the low-temperature drying time is 24 hours.

8. The preparation method according to claim 5, characterized in that: In step S3, the konjac flour solution is a solution of konjac flour and water in a mass volume ratio of g:mL=1:100; the mass ratio of konjac flour to liposome freeze-dried powder and microcrystalline cellulose is 1.6-2.4:20-30:2-4.

9. The preparation method according to claim 5, characterized in that: In step S3, the spray drying conditions are as follows: an inlet temperature of 110°C, a feed rate of 8 mL / min, an air flow rate of 300 L / h, and a nozzle diameter of 0.7 mm.

10. Use of the volatile oil liposome precursor obtained according to the preparation method according to any one of claims 4 to 9 in the preparation of tablets.